PURPOSE OF REVIEW: The present review highlights the recent findings on cardiovascular disease in rheumatoid arthritis (RA), and outlines the current concepts and prospects of cardiovascular disease detection and management in RA. RECENT FINDINGS: Over the past year the knowledge of cardiovascular disease in RA has been augmented by a number of studies further explicating the interplay between RA and cardiovascular risk factors and highlighting the impact of inflammatory measures, immune mediators and other markers as early determinants of cardiovascular disease in RA. Other studies reported potential beneficial effects on cardiovascular outcomes for some antirheumatic medications. SUMMARY: Knowledge of the increased burden of cardiovascular disease in RA is substantial and is continuously growing. Early detection, control and management of cardiovascular disease in RA appear to be a rapidly advancing field of research. However, much more work is needed to develop effective interventions to reduce cardiovascular morbidity and mortality in RA patients. More studies are needed to identify specific biomarkers for cardiovascular disease in RA and to develop cardiovascular risk scoring tools and evidence-based algorithms to promote more effective cardiovascular prevention and management of cardiovascular disease in RA.
PURPOSE OF REVIEW: The present review highlights the recent findings on cardiovascular disease in rheumatoid arthritis (RA), and outlines the current concepts and prospects of cardiovascular disease detection and management in RA. RECENT FINDINGS: Over the past year the knowledge of cardiovascular disease in RA has been augmented by a number of studies further explicating the interplay between RA and cardiovascular risk factors and highlighting the impact of inflammatory measures, immune mediators and other markers as early determinants of cardiovascular disease in RA. Other studies reported potential beneficial effects on cardiovascular outcomes for some antirheumatic medications. SUMMARY: Knowledge of the increased burden of cardiovascular disease in RA is substantial and is continuously growing. Early detection, control and management of cardiovascular disease in RA appear to be a rapidly advancing field of research. However, much more work is needed to develop effective interventions to reduce cardiovascular morbidity and mortality in RApatients. More studies are needed to identify specific biomarkers for cardiovascular disease in RA and to develop cardiovascular risk scoring tools and evidence-based algorithms to promote more effective cardiovascular prevention and management of cardiovascular disease in RA.
Authors: Maria Fernanda Brandão de Resende Guimarães; Marcus Vinícius Melo de Andrade; Carla Jorge Machado; Érica Leandro Marciano Vieira; Maria Raquel da Costa Pinto; Antônio Lúcio Teixeira Júnior; Adriana Maria Kakehasi Journal: Rheumatol Int Date: 2018-06-11 Impact factor: 2.631
Authors: Erin M Scanlon; Rekha Mankad; Cynthia S Crowson; Iftikhar J Kullo; Sharon L Mulvagh; Eric L Matteson; Zoran Kvrgic; John M Davis Journal: Clin Rheumatol Date: 2016-12-17 Impact factor: 2.980
Authors: Deborah F van Breukelen-van der Stoep; Derkjen van Zeben; Boudewijn Klop; Gert-Jan M van de Geijn; Hans J W Janssen; Mieke J M W Hazes; Erwin Birnie; Noelle van der Meulen; Marijke A De Vries; Manuel Castro Cabezas Journal: PLoS One Date: 2015-10-20 Impact factor: 3.240
Authors: Ingrid Demmelmaier; Annika Björk; Alyssa B Dufour; Birgitta Nordgren; Christina H Opava Journal: Arthritis Care Res (Hoboken) Date: 2018-03-25 Impact factor: 4.794
Authors: Victor M Rivera; Douglas R Jeffery; Bianca Weinstock-Guttman; Daena Bock; Fernando Dangond Journal: BMC Neurol Date: 2013-07-11 Impact factor: 2.474